Production (Stage)
Inhibikase Therapeutics, Inc.
IKT
$1.95
-$0.01-0.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.47% | 2,907.26% | -59.15% | -18.56% | -26.43% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.16% | 213.21% | -22.81% | -59.87% | 11.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -27.09% | -84.61% | 108.42% | 42.56% | 5.73% |
| Total Current Assets | -4.35% | 2,249.62% | -51.29% | -20.40% | -23.95% |
|
|
|||||
| Total Current Assets | -4.35% | 2,249.62% | -51.29% | -20.40% | -23.95% |
| Net Property, Plant & Equipment | -21.48% | -20.50% | -16.61% | -13.95% | -11.94% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -4.38% | 2,152.73% | -50.41% | -20.25% | -23.70% |
|
|
|||||
| Total Accounts Payable | 79.44% | -62.72% | 88.68% | 3.61% | 100.03% |
| Total Accrued Expenses | 31.09% | 23.99% | 6.24% | -18.87% | 10.96% |
| Short-term Debt | -- | -- | -59.56% | -36.81% | -26.51% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -32.31% | -23.90% | -4.60% | 0.66% | 0.73% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 129.02% | -23.92% | 32.47% | -12.49% | 23.11% |
|
|
|||||
| Total Current Liabilities | 129.02% | -23.92% | 32.47% | -12.49% | 23.11% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -59.56% | -36.81% | -26.51% |
| Capital Leases | -- | -- | -- | -56.09% | -35.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 129.02% | -23.92% | 31.56% | -13.08% | 21.61% |
|
|
|||||
| Common Stock & APIC | 2.38% | 131.57% | 0.18% | 4.19% | 0.58% |
| Retained Earnings | -14.49% | -14.74% | -7.55% | -6.93% | -6.95% |
| Treasury Stock & Other | 97.31% | -2,166.67% | 280.00% | 44.44% | -300.00% |
| Total Common Equity | -9.63% | 17,979.06% | -110.41% | -24.79% | -38.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.63% | 17,979.06% | -110.41% | -24.79% | -38.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.63% | 17,979.06% | -110.41% | -24.79% | -38.27% |
|
|
|||||